Day: April 8, 2026

MedCAD’s AccuStride® Receives FDA 510(k) Clearance for New Anatomical Lower Leg Region Tib/Fib Solution

April 8, 2026

DALLAS, April 8, 2026 /PRNewswire/ — Dallas-based MedCAD has received FDA 510(k) clearance of its AccuStride® lower leg tibia and fibula system, making these patient-specific precision devices available to surgeons. The unique design of the custom-made planning and surgical guides will enable orthopedic surgeons to correct multiple related pathologies and osteotomies in a single procedure.

Daré’s CEO Wants Everyone To Invest in Women’s Health, Starting With Her Company

April 8, 2026

Sabrina Martucci Johnson wants everyone to invest in her women’s health biotech Daré Bioscience. That means you, dear reader.

FDA approves Endospan’s aortic stent

April 8, 2026

Research suggests that over 120,000 patients suffer from aortic arch disease in the US and Europe annually, but only around 25% of patients are diagnosed or treated.

Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter

April 8, 2026

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial.

BD picks up CE mark for next-gen stent graft

April 8, 2026

BD (NYSE:BDX) announced today that it received CE mark approval for its Liverty TIPS stent graft system.

Supira gets FDA green light to conduct ventricular assist device study

April 8, 2026

Supira Medical announced today that it received FDA approval to initiate a new trial of its percutaneous ventricular assist device (pVAD).

MRI technique enables long-term tracking of transplanted stem cell-derived heart cells

April 8, 2026

Researchers at the Institute of Biomedical Engineering at the University of Toronto have demonstrated a new way to monitor transplanted stem-cell-derived heart cells using magnetic resonance imaging (MRI).

Gene-edited stem cells help five blood disorder patients stop transfusions in clinical trial

April 8, 2026

Stem cell transplantation could be a rapid and effective way to restore hemoglobin production in individuals with the blood disorder β-thalassaemia.

Sequencing method exposes hidden gaps in immune signaling by tracking RNA and protein together

April 8, 2026

A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic intent, but real-time activity.

Researchers use earbuds to monitor heart health

April 8, 2026

Carnegie Mellon researchers have proven that widely available earbuds can double as heart-monitoring devices, capturing subtle cardiac activity with near-clinical accuracy and potentially expanding access to long-term, at-home care.

Blog

- April 8, 2026

MedCAD’s AccuStride® Receives FDA 510(k) Clearance for New Anatomical Lower Leg Region Tib/Fib Solution

Daré’s CEO Wants Everyone To Invest in Women’s Health, Starting With Her Company

FDA approves Endospan’s aortic stent

Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter

BD picks up CE mark for next-gen stent graft

Supira gets FDA green light to conduct ventricular assist device study

MRI technique enables long-term tracking of transplanted stem cell-derived heart cells

Gene-edited stem cells help five blood disorder patients stop transfusions in clinical trial

Sequencing method exposes hidden gaps in immune signaling by tracking RNA and protein together

Researchers use earbuds to monitor heart health